|  |  |  | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|---|
(N = 260) |  | Recurrence (n = 38) | No recurrence (n = 222) | OR (95% CI) | P-value | OR (95% CI) | P-value |
Patient factor | Male | 24 (63.1%) | 110 (49.5%) | 1.75 (0.87–3.63) | 0.12 |  |  |
Age (year) | 53.58 ± 11.7 | 58.3 ± 10.84 | 0.96 (0.93–0.99) | 0.01* | 0.96 (0.93–0.99) | 0.02* | |
Hypertension (%) | 25 (65.7) | 132 (59.4) | 1.31 (0.65–2.77) | 0.46 |  |  | |
Smoking (%) | 15 (39.4) | 100 (45.0) | 0.80 (0.39–1.59) | 0.52 |  |  | |
Aneurysm factor | Rupture (%) | 21 (55.2) | 56 (25.2) | 3.66 (1.81–7.52) | 0.001* | 3.55 (1.62–7.91) | 0.001* |
Maximal diameter | 6.3 ± 3.0 | 5.17 ± 2.1 | 1.20 (1.06–1.37) | 0.005* | 1.19 (1.03–1.39) | 0.02 * | |
Size ratio | 3.0 ± 1.6 | 2.3 ± 1.0 | 1.50 (1.17–1.95) | 0.001* | 1.07 (0.69–1.68) | 0.76 | |
Inflow angle | 152.8 ± 23.0 | 147.9 ± 29.1 | 1.01 (0.99–1.02) | 0.11 |  |  | |
Dome direction (Anterior, %) | 29 (76.3) | 116 (52.5) | 2.94 (1.38–6.86) | 0.007* | 3.86 (1.67–9.94) | 0.002* | |
Hypoplastic A1 (%) | 13 (34.2) | 69 (31.0) | 1.15 (0.54–2.35) | 0.70 |  |  | |
Treatment factor | Stent usage (%) | 5 (13.1) | 47 (21.1) | 0.56 (0.19–1.41) | 0.25 |  |  |
Raymond class (II or III, %) | 18 (47.3) | 75 (33.7) | 1.76 (0.87–3.54) | 0.10 |  |  |